C-3VJ8Alkahest
plasma proteomics, multiomics, AI
replacementreplacingbiologic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-3VJ8
C-3VJ8C-3VJ8plasma proteomics, multiomics, AI
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Alkahest plasma proteomics, multiomics, AI
Alkahest is a Grifols subsidiary focused on research and drug discovery using plasma knowledge. The company combines artificial intelligence, integrative multiomics analysis, real-world data, and plasma protein expertise. Its work is based on the premise that changes in the plasma proteome influence human biology and may provide biomarkers for predicting, diagnosing, and treating disease.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Alkahest — Far from goals · Lower middle. Derived deterministically from 7 extracted project(s). Most-advanced status: undisclosed. Band: far. Modifiers: +5 depth (4 programs at undisclosed).…
Source: Deterministic